Stella-Jones (OTCMKTS:STLJF) Shares Gap Down Following Weak Earnings

Stella-Jones Inc. (OTCMKTS:STLJF) shares gapped down before the market opened on Thursday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $62.25, but opened at $55.12. Stella-Jones shares last traded at $55.12, with a volume of 106 shares changing hands.

The company reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $0.84 by ($0.02). Stella-Jones had a return on equity of 15.08% and a net margin of 8.66%.The company had revenue of $568.67 million for the quarter, compared to the consensus estimate of $583.31 million.

Analyst Ratings Changes

A number of analysts recently weighed in on STLJF shares. Scotiabank upgraded shares of Stella-Jones from a “sector perform” rating to an “outperform” rating in a research report on Thursday, January 29th. Desjardins reiterated a “buy” rating on shares of Stella-Jones in a research report on Thursday. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has an average rating of “Buy”.

Stella-Jones Stock Down 3.8%

The company has a market capitalization of $2.87 billion and a P/E ratio of 80.94. The firm’s 50 day moving average price is $65.53 and its two-hundred day moving average price is $63.95. The company has a current ratio of 7.40, a quick ratio of 1.34 and a debt-to-equity ratio of 0.64.

About Stella-Jones

Stella-Jones Inc is a North American producer and distributor of pressure-treated wood products used in infrastructure, utility and residential applications. The company’s core offerings include treated railroad ties, utility poles, crossarms, landscape timbers and posts designed to withstand environmental stresses and extend service life. These products support a range of end markets from railways and power transmission to fencing and outdoor construction.

Founded in 1970 and headquartered in Montreal, Canada, Stella-Jones has grown through both organic expansion and targeted acquisitions to establish a network of manufacturing and treatment facilities across Canada and the United States.